Michael is Global Head of EPRM (External Partner Risk Management) at Novartis since 2021.

Prior roles within Novartis include CFO Oncology business unit, region LACan based out of New Jersey, CFO Oncology business unit, Germany, Head Key Account Management Backoffice, Germany.

Before joining Novartis, Michael worked for Merck KGaA in several Finance roles including M&A, Business development and licensing, as well as for VWR International, USA in financial and management reporting.

Michael holds a Diploma in Business Administration from Leipzig Graduate School of Management.